September 2022 Issue: Mirati Therapeutics (SYM: MRTX)
- Dylan Jovine
- Wednesday, September 21, 2022
Today I want to talk to you about KRAS mutations in cancer treatment. But first, we have three stocks to sell today. We’ll be taking profits on two and a loss on one.
UPDATE: ChemoCentryx (CCXI) up 107% on Takeover
- Dylan Jovine
- Thursday, August 4, 2022
Shares of one of ChemoCentrix (SYM: CCXI) are up $26 today after Amgen agreed to buy the company for $4 billion in cash. The stock is selling for $50.13.
September 2022 Issue: Mirati Therapeutics (SYM: MRTX)
- Dylan Jovine
- Wednesday, September 21, 2022
Today I want to talk to you about KRAS mutations in cancer treatment. But first, we have three stocks to sell today. We’ll be taking profits on two and a loss on one.
UPDATE: ChemoCentryx (CCXI) up 107% on Takeover
- Dylan Jovine
- Thursday, August 4, 2022
Shares of one of ChemoCentrix (SYM: CCXI) are up $26 today after Amgen agreed to buy the company for $4 billion in cash. The stock is selling for $50.13.
Categories
Recent posts
Tags
Connect with Us
Get FREE Weekly Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
